Karol E Watson

Professor advancing research in cardiovascular risk reduction therapy, Karol E. Watson, MD, PhD, is a distinguished Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles. With a profound dedication to improving cardiovascular health, Dr. Watson's research primarily focuses on the development and refinement of therapies aimed at reducing cardiovascular risk, with a particular emphasis on the eligibility criteria within the United States. Dr. Watson's recent scholarly contributions have significantly advanced the understanding of cardiovascular health. Her work delves into the intricate relationships between coronary artery calcium and cognitive decline, offering new insights into how cardiovascular conditions may impact cognitive functions. Additionally, she has explored the connection between urinary cortisol levels and cardiovascular events, providing a deeper understanding of how stress-related hormones can influence heart health. In her pursuit of optimizing cardiovascular risk reduction strategies, Dr. Watson has also examined the eligibility criteria based on the SELECT trial. Her research in this area seeks to refine and enhance the criteria used to determine patient eligibility for cardiovascular therapies, ensuring that treatments are both effective and accessible to those who need them most. Dr. Watson's contributions to the field of cardiovascular medicine are widely recognized, and her research continues to shape the future of cardiovascular risk management. Her work not only advances scientific knowledge but also has a tangible impact on clinical practices, ultimately improving patient outcomes and quality of life.